Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.

Ascorbic acid kills Epstein-Barr virus positive Burkitt lymphoma cells and Epstein-Barr virus transformed B-cells in vitro, but not in vivo.

Shatzer AN, Espey MG, Chavez M, Tu H, Levine M, Cohen JI.

Leuk Lymphoma. 2013 May;54(5):1069-78. doi: 10.3109/10428194.2012.739686. Epub 2012 Nov 15.

2.

Tubacin kills Epstein-Barr virus (EBV)-Burkitt lymphoma cells by inducing reactive oxygen species and EBV lymphoblastoid cells by inducing apoptosis.

Kawada J, Zou P, Mazitschek R, Bradner JE, Cohen JI.

J Biol Chem. 2009 Jun 19;284(25):17102-9. doi: 10.1074/jbc.M809090200. Epub 2009 Apr 22.

3.

Combination of SAHA and bortezomib up-regulates CDKN2A and CDKN1A and induces apoptosis of Epstein-Barr virus-positive Wp-restricted Burkitt lymphoma and lymphoblastoid cell lines.

Hui KF, Leung YY, Yeung PL, Middeldorp JM, Chiang AK.

Br J Haematol. 2014 Dec;167(5):639-50. doi: 10.1111/bjh.13089. Epub 2014 Aug 25.

PMID:
25155625
4.
5.

Bortezomib and SAHA synergistically induce ROS-driven caspase-dependent apoptosis of nasopharyngeal carcinoma and block replication of Epstein-Barr virus.

Hui KF, Lam BH, Ho DN, Tsao SW, Chiang AK.

Mol Cancer Ther. 2013 May;12(5):747-58. doi: 10.1158/1535-7163.MCT-12-0811. Epub 2013 Mar 8.

6.

Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.

Roychowdhury S, Baiocchi RA, Vourganti S, Bhatt D, Blaser BW, Freud AG, Chou J, Chen CS, Xiao JJ, Parthun M, Chan KK, Eisenbeis CF, Ferketich AK, Grever MR, Chen CS, Caligiuri MA.

J Natl Cancer Inst. 2004 Oct 6;96(19):1447-57.

PMID:
15467034
7.

Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein-Barr virus infection.

Iwata S, Yano S, Ito Y, Ushijima Y, Gotoh K, Kawada J, Fujiwara S, Sugimoto K, Isobe Y, Nishiyama Y, Kimura H.

Int J Cancer. 2011 Nov 1;129(9):2263-73. doi: 10.1002/ijc.25873. Epub 2011 Apr 4.

8.

Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.

Shirley CM, Chen J, Shamay M, Li H, Zahnow CA, Hayward SD, Ambinder RF.

Blood. 2011 Jun 9;117(23):6297-303. doi: 10.1182/blood-2011-01-332379. Epub 2011 Mar 29.

9.

Antitumor activities of valproic acid on Epstein-Barr virus-associated T and natural killer lymphoma cells.

Iwata S, Saito T, Ito Y, Kamakura M, Gotoh K, Kawada J, Nishiyama Y, Kimura H.

Cancer Sci. 2012 Feb;103(2):375-81. doi: 10.1111/j.1349-7006.2011.02127.x. Epub 2011 Nov 22.

10.
11.

Combined proteasome and Bcl-2 inhibition stimulates apoptosis and inhibits growth in EBV-transformed lymphocytes: a potential therapeutic approach to EBV-associated lymphoproliferative diseases.

Srimatkandada P, Loomis R, Carbone R, Srimatkandada S, Lacy J.

Eur J Haematol. 2008 May;80(5):407-18. doi: 10.1111/j.1600-0609.2008.01044.x. Epub 2008 Jan 23.

PMID:
18221384
12.

Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.

Destro F, Sforza F, Sicurella M, Marescotti D, Gallerani E, Baldisserotto A, Marastoni M, Gavioli R.

Immunology. 2011 May;133(1):105-14. doi: 10.1111/j.1365-2567.2011.03416.x. Epub 2011 Feb 22.

13.

Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.

Hutchings IA, Tierney RJ, Kelly GL, Stylianou J, Rickinson AB, Bell AI.

J Virol. 2006 Nov;80(21):10700-11. Epub 2006 Aug 18.

14.
15.

The Epstein-Barr virus latent membrane protein-1 (LMP1) induces interleukin-10 production in Burkitt lymphoma lines.

Nakagomi H, Dolcetti R, Bejarano MT, Pisa P, Kiessling R, Masucci MG.

Int J Cancer. 1994 Apr 15;57(2):240-4.

PMID:
8157362
16.

Resveratrol inhibits proliferation and survival of Epstein Barr virus-infected Burkitt's lymphoma cells depending on viral latency program.

De Leo A, Arena G, Stecca C, Raciti M, Mattia E.

Mol Cancer Res. 2011 Oct;9(10):1346-55. doi: 10.1158/1541-7786.MCR-11-0145. Epub 2011 Aug 19.

17.

Epstein-Barr virus-encoded Bcl-2 homologue functions as a survival factor in Wp-restricted Burkitt lymphoma cell line P3HR-1.

Watanabe A, Maruo S, Ito T, Ito M, Katsumura KR, Takada K.

J Virol. 2010 Mar;84(6):2893-901. doi: 10.1128/JVI.01616-09. Epub 2009 Dec 30.

18.

Three restricted forms of Epstein-Barr virus latency counteracting apoptosis in c-myc-expressing Burkitt lymphoma cells.

Kelly GL, Milner AE, Baldwin GS, Bell AI, Rickinson AB.

Proc Natl Acad Sci U S A. 2006 Oct 3;103(40):14935-40. Epub 2006 Sep 25.

19.

Gene array identification of Epstein Barr virus-regulated cellular genes in EBV-converted Burkitt lymphoma cell lines.

Baran-Marszak F, Fagard R, Girard B, Camilleri-Broët S, Zeng F, Lenoir GM, Raphaël M, Feuillard J.

Lab Invest. 2002 Nov;82(11):1463-79.

PMID:
12429807
20.

Supplemental Content

Support Center